Details About Generic Salt ::  Ergoloid

Main Medicine Class:: Psychotherapeutic   

(err-GO-loyd- MEH-suh-lates)

Gerimal, Hydergine, Hydergine LC, Niloric

Class: Psychotherapeutic

Drugs Class ::

 Action Unknown; may increase brain metabolism, possibly increasing cerebral blood flow.

Indications for Drugs ::

 Indications Treatment of age-related decline in mental capacity, primary progressive dementia, Alzheimer’s dementia, multi-infarct dementia and senile onset.

Drug Dose ::

 Route/Dosage

ADULTS: PO/SL 1 to 2 mg tid (up to 12 mg/day has been used).

Contraindication ::

 Contraindications Hypersensitivity to ergoloid mesylates or other ergot alkaloids; acute or chronic psychosis.

Drug Precautions ::

 Precautions

Pregnancy: Pregnancy category undetermined. Lactation: Undetermined. Children: Safety and efficacy not established. Special risk patients: Administer drug with caution to patients with history of bradycardia or hypotension. Liver impairment: Elimination of drug may be affected.

Drug Side Effects ::

 Adverse Reactions

CV: Orthostatic hypotension; bradycardia. DERM: Rash. GI: Transient nausea; GI disturbances; sublingual irritation.

Drug Mode of Action ::  

 Action Unknown; may increase brain metabolism, possibly increasing cerebral blood flow.

Drug Interactions ::

 Interactions None well documented.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies.
• Potentially reversible and treatable conditions should be ruled out prior to use of ergoloid mesylates in treating age-related decline of mental capacity.
• Assess patient’s mental status (alertness, memory, orientation, mood, emotional liability and self-care) prior to and during administration of drug.
• Monitor BP and pulse rate prior to initiation of therapy and at periodic intervals during therapy.
• Take appropriate safety measures if lightheadedness, weakness or changes in mental status develop.

Drug Storage/Management ::

 Administration/Storage

• Instruct patient to allow SL tablets to completely dissolve under tongue; do not allow patient to swallow, crush or chew tablet.
• Do not permit patient to eat, drink or smoke while SL tablet is dissolving.
• Store in tightly closed, light-resistant container at room temperature.

Drug Notes ::

 Patient/Family Education

• Teach patient how to decrease effects of orthostatic hypotension by rising slowly from supine position and dangling feet for few min before standing.
• Instruct patient to avoid alcohol consumption, which may enhance hypotensive effect.
• Caution patient not to take otc cough, cold and allergy preparations that contain alcohol.
• Instruct patient to avoid excessive exposure to cold since temperature regulation may be impaired.
• Instruct patient to notify physician if adverse reactions occur.
• Advise patient/family that it may require 3–4 wk and up to 6 mo to determine clinical effectiveness of drug.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.